GE HealthCare Technologies (GEHC) on Wednesday posted first-quarter results that came in better than analysts had expected, but the former General Electric division lowered its full-year profit outlook because of tariffs.

The medical device maker reported adjusted earnings per share of $1.01 on revenue that increased 3% year-over-year to $4.78 billion. Analysts polled by Visible Alpha had forecast $0.92 and $4.66 billion, respectively.

Adjus🉐ted EPS Forecast Lowered Due to $0.85-Per-Share Tariff Impact

However, GE HealthCare lowered its full-year adjusted EPౠS forecast because of announced tariffs, which it said will have an impact of $0.85 per share. The company said it now expects adjusted EPS of $3.90 to $4.10, ꦅdown from the prior range of $4.61 to $4.75. It still expects organic revenue growth of 2% to 3%.

"Regarding the current global trade environment, we are actively driving mitigation actions," CEO Peter Arduini said. "We continue to see strong customer demand in many of the markets we serve and are well-positioned to drive long-term value as we invest in future innovation."

Also on Wednesday, the compa🦩ny said its board has approved a stock buyback plan of up to $1 billion.

GE HealthCare shares rose 3% shortly after markets opened Wednesday. Entering the d꧟ay, they had lost about 13% of their value since the ℱstart of the year.

Last week, the firm's former corporate brethren 澳洲幸运5开奖号码历史查询:GE Vernova (GEV) and 澳洲幸运5开奖号码历史查询:GE Aerospace (GE) topped Q1 estimates and affirmed their full-year ou𒈔tlܫooks.

UPDATE—This article has been updated with the latest share price information.